Table 2

MRSA prevalence among patients and residents in long-term care facilities

NO.

Author (First)

Study design

Screening policy

Results

Quality Rating3

Country, Year of Publication

Study period, dates (months)

Study, setting (no. of units) (n)

Basic number of cases potentially eligible (n)

Study population (no. of residents) (n)

Screening methods

Swabbing sites

Number of MRSA patients colonised (C) or infected (I) (n)

Proportion of MRSA

% MRSA among patients Mean (95% CI)1Range2

% MRSA among S. aureus isolates Mean (95% CI)1


1

Baldwin

[36]

Northern Ireland

2009

2005-2006 (9)

NH-E (45)

1.678

1.1114

Non-selective on one day in each unit

Nares, urine, wounds, inv.devices

267 (C)

23.3 (18.8-27.7)

Range, 0 to 73

Good

1Y; 2Y; 3Y; 4Y; 5Y; 6Y; 7N

2

Barr

[38]

UK

2007

2005 (2)

Care homes for the elderly (39)

1.342

7154

Non-selective

Nose

159 (C)

22.0 (18.0-27.0)

Range, 0 to 50

54.0

Fair

1N; 2N; 3Y; 4Y; 5Y; 6Y; 7N

3

Baum, von

[37]

Germany

2002

1999-2000 (12)

NH-E (47)

3.864

3.2364

Non-selective

Nares, skin defects

36 (C)

1.1 (0.75-1.47)

Range, 0 to 18.2

Fair

1N; 2Y; 3Y; 4Y; 5Y; 6N; 7N

4

Brugnaro

[39]

Italy

2009

2006 (1)

NH-E (2 with 15 units)

570

5514

Non-selective on a single day in each unit

Nares

43 (C)

7.8 (5.7-10.4)

Range, 0 to 18

Fair

1N; 2Y; 3Y; 4Y; 5Y; 6N; 7N

5

Cretnik

[40]

Slovenia

2005

2001 (1)

NH-E (1)

127

107

Non-selective

Nares, skin lesions

10 (C)

9.3

Poor

1N; 2N; 3Y; 4Y; 5N; 6?; 7N

6

Denis

[33]

Belgium

2009

2005 (9)

A random sample of NH-E (60)

NA

2.953

Non-selective on the same day in each unit

Nares, throat, wounds, cath. urine

587 (C)

19.5 (16.4-21.5)

Range, 2 to 42.9

39.1

Fair

1N; 2Y; 3Y; 4Y; 5Y; 6N; 7Y

7

Heuck

[41]

Germany

2000

NA

NH-E (31)

?

1.3424

Non-selective

Nares, throat, wounds

32 (C)

2.4

Range, 0 to 2.9

6.0

Poor

1N; 2N; 3Y; 4N; 5N; 6N; 7Y

8

Heudorf

[42]

Germany

2001

1999-2000 NA

NH-E (7); geriatric RC (1)

?

NH-E: 359 RC: 424

Non-selective

Nose, throat

NH-E: 8 (C) RC: 2 (C)

NH-E: 2.2 RC: 4.8

Fair

1N; 2N; 3Y; 4Y; 5Y; 6N; 7Y

9

Hoefnagels-Schuermans

[43]

Belgium

2002

1997 (3)

NH-E (17)

?

2.857

Non-selective; one day sampling in each unit

Nose, perineum

141 (C)

4.9 (4.38-6.09)

19.1

Poor

1N; 2Y; 3N; 4N; 5N; 6Y; 7N

10

Neuhaus

[44]

Germany

2002

2000-2001 (12)

NH-E (61)

?

1.0574

Non-selective

Nose, throat, wounds

32 (C) 3 (I)

3.0 (2.1-4.2)

6.3 (4.3-8.8)

Fair

1Y; 2N; 3Y; 4N; 5N; 6N; 7Y

11/1

Woltering

[45]

Germany

2008

NA (4)

NH-E (5)

441

2654

Non-selective

on a 2-days period in each unit

Nose, throat, wounds

4 (C)

2.3 (0.8-4.9)

5.9

Good

1N; 2Y; 3Y; 4Y; 5Y; 6N; 7Y


1: Pooled mean calculated as a combined prevalence rate over all units with 95% CI.

2: Range within the individual units.

3: Levels for study quality: Good (= 6 and 7 points), fair (= 3 - 5 points), poor (= 1 and 2 points). Numbers belong to the questions as illustrated in Table 1.

4: Participants who were able to give informed consent or informed consent were given by their relatives. Abbreviations: CI, Confidence intervals; N, no; NH-(E), Nursing home for the elderly; RC, Rehabilitation centre; Y, Yes; NA, No Answer; ?, unclear or missing information.

Dulon et al. BMC Infectious Diseases 2011 11:138   doi:10.1186/1471-2334-11-138

Open Data